MISTLETOE THERAPY

MISTLETOE

THERAPY

A new observational study has found that patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary mistletoe treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone.
The 2nd most studied mode of CANCER treatment after the conventional ones with over 130 clinical trials and about 3000 published research paper to its credit.
Patented Oral Formulation of Mistletoe Extracts for cancer Management has the highest concentration of lectins, viscotoxins and polysaccharides for better induction of apoptosis and better immunomodulation.

MISTLETOE

FOR LUNG CANCER

Patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary mistletoe treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone, a new observational study has found.

Where is it available?

● Mistletoe is available nearly in all the continents and countries.
● Diluted forms of mistletoe extract are available in the United States.

Why Oral Mistletoe?

Difference between oral and injectable mistletoeOral Mistletoe :
● We can give high dose in oral.
● Oral Mistletoe is approved by FDA
● Regulatory Oral Mistletoe has been approved by regulatory authorities of FDA / FSSAI.
Injectable Mistletoe :
● We can provide only low dose
● Injectable Mistletoe is not approved by FDA.

Book a appointment

Patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary mistletoe treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone, a new observational study has found.